NCT06771674 2025-09-09Real-world Study of First Line Pembrolizumab- or Nivolumab-treated HPV-positive Recurrent/Metastatic Oropharyngeal Squamous Cell CarcinomaHookipa Biotech GmbHCompleted662 enrolled
NCT06654999 2025-07-09How Consistent is the Output of DERM, When Used to Assess Images of Potentially Cancerous Skin Lesions.Skin Analytics LimitedCompleted115 enrolled